Skip to playerSkip to main content
  • 16 minutes ago
A recent review conducted by Cochrane, which analyzed nine studies involving 537 individuals suffering from insomnia, concluded that medical cannabis provided minimal to no significant enhancements in sleep quality, duration, or daytime performance when compared to a placebo. Participants reported experiencing mild adverse effects, including dry mouth and dizziness. The reliability of the findings was assessed as low to very low, with the longest study spanning 12 weeks. The principal investigator emphasized that the current body of research does not sufficiently determine its effectiveness. It is advised to consult a healthcare professional prior to considering its use for sleep issues.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.

ai-generated

Category

🗞
News
Transcript
00:00Millions of Americans struggle to sleep, and some turn to medical cannabis.
00:04A new Cochrane review looked at the evidence, and the answer is not what many hoped.
00:09Researchers pooled nine trials with 537 adults who have insomnia.
00:14Compared with placebo, medical cannabis brought little to no clinically meaningful improvement in sleep quality.
00:20Total sleep time, sleep satisfaction, or daytime functioning.
00:24People taking it were also more likely to report mild side effects like dry mouth and dizziness.
00:30Quality of life may have improved a little, but the certainty of that finding was very low.
00:35The evidence overall was rated low to very low, because trials were small and results varied.
00:41The longest study lasted just 12 weeks, so long-term effects are unknown.
00:45Lead author Dr. Lucia Varela said the research is not sufficient to reliably say whether it helps.
00:51If you have trouble sleeping, talk to your doctor before trying cannabis products.
00:56Disclosure. This video contains stock footage and content created or enhanced using AI-assisted tools.

Recommended